Multiple (e.g., RevealDx, Optellum, LungLife AI, Qure.ai, Arterys, DeepHealth, HeartLung.AI)

Multiple (e.g., Seattle, WA for RevealDx; Oxford, UK for Optellum; London, UK for LungLife AI; Mumbai, India for Qure.ai; San Francisco, CA for Arterys; Cambridge, MA for DeepHealth)  All United States companies → — Founded Multiple (e.g., 2018 for RevealDx; 2016 for Optellum; 2018 for LungLife AI; 2016 for Qure.ai; 2011 for Arterys; 2017 for DeepHealth)
Imaging AI Specialist Specialty-Focused AI
Multiple (e.g., Seed to Series C for various companies)

Products

Lung AI
Multiple (e.g., RevealDx, Optellum, LungLife AI, Qure.ai, Arterys, DeepHealth, HeartLung.AI)
Cardiology AI
Exo is pioneering a high-performance, handheld ultrasound platform that uses artificial intelligence for imaging and therapeutic applications. By delivering affordable, easy-to-use medical imaging, Exo empowers healthcare professionals around the world to make critical, real-time decisions that improve patient outcomes.

See all 1 product →

About Multiple (e.g., RevealDx, Optellum, LungLife AI, Qure.ai, Arterys, DeepHealth, HeartLung.AI)

The companies listed (RevealDx, Optellum, LungLife AI, Qure.ai, Arterys, DeepHealth, HeartLung.AI) represent a diverse group of healthcare AI innovators, each focusing on critical areas within medical diagnostics and treatment. For physicians, these technologies offer the potential to significantly enhance diagnostic accuracy, streamline workflows, and personalize patient care. For example, companies like Optellum and RevealDx are developing AI-powered solutions for early lung cancer detection and characterization, aiming to improve prognoses by identifying malignant nodules at an earlier stage. These systems often integrate with existing imaging modalities (e.g., CT scans) to provide quantitative analyses and risk stratification, assisting radiologists and pulmonologists in making more informed decisions regarding patient management, including surveillance or biopsy recommendations.

Other companies, such as Qure.ai and Arterys, are expanding AI applications across various imaging disciplines, including radiology and cardiology. Qure.ai, for instance, offers AI solutions for interpreting X-rays and CT scans to detect a range of abnormalities, from tuberculosis to intracranial hemorrhages, particularly valuable in high-volume settings or areas with limited specialist access. Arterys provides a cloud-based AI platform for medical imaging, enabling advanced visualization and quantitative analysis for specialties like cardiology and oncology. DeepHealth focuses on AI for mammography, aiming to improve breast cancer detection rates and reduce false positives. LungLife AI and HeartLung.AI are also contributing to this landscape, likely with specialized AI tools for respiratory and cardiovascular health, respectively. Collectively, these companies are leveraging machine learning and deep learning to extract actionable insights from complex medical data, ultimately striving to improve diagnostic precision, reduce clinician workload, and enhance patient outcomes across a spectrum of diseases.

Focus Areas

AI-powered medical imaging analysis early disease detection (e.g. lung cancer breast cancer tuberculosis) diagnostic support risk stratification quantitative imaging radiology workflow optimization cardiovascular health respiratory health.

Business Intelligence

TechnologyAI-enabled, radiomics-based software

What Physicians Need to Know

Early Lung Cancer Detection & Risk Stratification
Several companies, including Optellum, RevealDx, LungLife AI, and HeartLung.AI, are heavily focused on early lung cancer detection. Optellum's Virtual Nodule Clinic with Lung Cancer Prediction (LCP) AI is FDA-cleared and uses deep learning and radiomics to analyze CT images and provide a cancer risk score, outperforming standard models. RevealDx offers RevealAI-Lung, an AI-powered decision support software that characterizes lung nodules and generates a Malignancy Similarity Index (mSI) to help radiologists make informed follow-up recommendations. LungLife AI focuses on early detection from a simple blood draw, enhanced by AI, to provide additional information for indeterminate lung nodules. HeartLung.AI also aims for early detection and prevention of lung cancer using AI-enabled chest CT scans.
AI-Powered Medical Imaging Analysis (General)
Qure.ai specializes in AI-based healthcare solutions for interpreting medical imaging like X-rays, CT scans, and MRIs, with tools for detecting abnormalities in chest X-rays (qXR) and analyzing head CT scans (qER). Arterys provides a dedicated medical imaging platform with AI-enhanced workflow solutions across various specialties, including oncology and cardiology. DeepHealth offers a comprehensive AI-powered health informatics portfolio, including solutions for breast, chest, neuro, prostate, and thyroid health, aiming to optimize diagnostic workflows.
Cardiovascular Health
HeartLung.AI is a leader in AI-enabled cardiovascular imaging and preventive cardiology. Their AI-CVD platform transforms routine CT imaging into a comprehensive cardiovascular risk assessment, including automated coronary artery calcium assessment (AutoCAC, AI-CAC 'Agatston 2.0'), AI-derived cardiac chamber volumetry (AutoChamber AI), and cardiometabolic phenotyping. DeepHealth's Chest Suite also includes leading AI-powered coronary artery calcification tools. Arterys' Cardio AI analyzes cardiovascular magnetic resonance images to detect edges and assess the heart and major vessels.
Radiology Workflow Optimization & Diagnostic Support
Many of these companies aim to optimize radiology workflows. Qure.ai's AI models are designed to expedite treatment pathways and improve radiology workflows. Arterys' solutions reduce time spent on repetitive tasks and improve workflow. DeepHealth's DeepHealth OS is a cloud-native operating system powered by clinical AI to improve disease detection and efficiently orchestrate patient engagement and care delivery. RevealDx's RevealAI-Lung integrates directly into PACS, vastly improving workflow.
Tuberculosis (TB) Detection
Qure.ai has been instrumental in tuberculosis (TB) screening, utilizing its AI algorithms to accurately and efficiently identify TB cases, particularly in regions like Africa.
Breast Cancer Detection
DeepHealth offers Breast Solutions for standardizing breast cancer care across screening and diagnostic workflows, with studies showing a 21% increase in breast cancer detection rates. Arterys' Breast AI tool analyzes digital tomosynthesis images and mammograms to measure breast density, detect calcifications and abnormalities, and assess quality for breast cancer diagnosis and personalized risk assessment.
Neurological & Other Specialties
DeepHealth provides Neuro Solutions to assess and monitor neurodegenerative changes. Arterys' Neuro AI suite offers tools for CT and MRI neuroimaging analysis for early stroke diagnosis, quantification of white matter lesions, and tumor diagnosis and monitoring. DeepHealth also has solutions for prostate and thyroid health.
Physician Tip

For physicians, these AI solutions offer enhanced diagnostic accuracy and efficiency, potentially leading to earlier disease detection and improved patient outcomes. The ability to triage high-risk patients more effectively, reduce unnecessary invasive procedures, and streamline reporting can significantly optimize clinical workflows. Many platforms integrate seamlessly with existing PACS and EHR systems, providing actionable insights directly within familiar environments. The AI acts as a 'second read' or 'super radiologist,' detecting subtle features that the human eye might miss, thereby elevating diagnostic performance. The quantitative imaging biomarkers provided can also aid in personalized treatment plans and risk stratification beyond traditional methods.

Many of these AI platforms are designed for seamless integration with existing Picture Archiving and Communication Systems (PACS) and Electronic Health Records (EHR) systems. For example, Optellum's Virtual Nodule Clinic integrates with EHR and PACS. RevealDx's RevealAI-Lung integrates directly into PACS. Arterys offers a single and seamless integration to provider hospital systems. HeartLung.AI's AI-CVD platform is cloud-enabled and accessible without hardware or software installation. These integrations aim to minimize disruption to current workflows and maximize the utility of AI-driven insights within the clinical setting.

Products by Multiple (e.g., RevealDx, Optellum, LungLife AI, Qure.ai, Arterys, DeepHealth, HeartLung.AI)

1 product in the directory

Lung AI
Multiple (e.g., RevealDx, Optellum, LungLife AI, Qure.ai, Arterys, DeepHealth, HeartLung.AI)
Cardiology AI
Exo is pioneering a high-performance, handheld ultrasound platform that uses artificial intelligence for imaging and therapeutic applications. By delivering affordable, easy-to-use medical imaging, Exo empowers healthcare professionals around the world to make critical, real-time decisions that improve patient outcomes.

Videos

News, demos, and interviews about Multiple (e.g., RevealDx, Optellum, LungLife AI, Qure.ai, Arterys, DeepHealth, HeartLung.AI).

Loading videos...

Videos load interactively. If none appear, search YouTube for Multiple (e.g., RevealDx, Optellum, LungLife AI, Qure.ai, Arterys, DeepHealth, HeartLung.AI) →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Companies like Arterys offer AI-driven solutions such as Lung AI for processing lung CT scans and tracking abnormalities like lung nodules, and Cardio AI for cardiovascular imaging. Qure.ai provides AI software for detecting abnormalities across multiple radiology modalities, including Chest X-rays, Chest CT, Head CT, and Musculoskeletal X-rays, with specific FDA-cleared products for pulmonary nodules and intracranial hemorrhage. AI algorithms are generally used to enhance the accuracy and efficiency of medical image analysis, assisting in the early detection of diseases like lung cancer, breast cancer, and tuberculosis by identifying subtle patterns that might be missed by the human eye.
Qure.ai, for example, is committed to high standards of quality, safety, and regulatory compliance, holding certifications like EU MDR (CE Class IIb) and being compliant with HIPAA and GDPR. They ensure data is de-identified before cloud processing and adhere to standards like ISO 13485:2016 for software development and IEC 62304 for IT security. Arterys also emphasizes secure data access and efficient workflows, particularly with its collaboration with Amazon HealthLake Imaging, a HIPAA-eligible capability for storing and analyzing medical images.
While specific pricing models are not readily available in the provided information, the value proposition often revolves around improving diagnostic accuracy, increasing efficiency, and optimizing workflows. These benefits can lead to earlier disease detection, potentially reducing the need for invasive procedures, shortening hospital stays, and improving patient outcomes, which can translate into cost savings and improved resource allocation for healthcare systems.
The integration of AI into radiology workflows is designed to assist radiologists and clinical teams, not replace them, by automating tasks, prioritizing urgent cases, and aiding in report generation. Companies aim to provide user-friendly interfaces and systems that learn from radiologist feedback to improve over time. Qure.ai also focuses on building end-user trust by providing education and training on AI's capabilities and limitations to empower healthcare providers.
Arterys has established partnerships with various entities, including GE Healthcare for cardiac imaging platforms, Tempus and Amazon Web Services (AWS) for cloud-based medical imaging storage and analysis, and Ambra Health for integrating AI applications into clinical workflows. They also partner with companies like DeepLook Medical for automated segmentation tools and InferVision for AI-driven oncology solutions. Qure.ai has collaborations with organizations like NITI Aayog in India and the Ministry of Health in the UAE to deploy their solutions.
While specific financial stability details are not provided for all companies, the general trend in the AI in healthcare market indicates rapid growth and significant investment. Companies like Arterys have secured significant financing rounds to support their vision of transforming medical imaging. The long-term vision for these companies is to continue advancing AI's role in enhancing diagnostic accuracy, improving workflow efficiency, enabling personalized medicine, and ultimately leading to better patient outcomes.
AI plays a crucial role in risk stratification by analyzing medical images and clinical data to identify patterns that may indicate a higher risk for certain conditions, even before symptoms appear. In quantitative imaging, AI algorithms can precisely measure and track changes in lesions, organ volumes, and blood flow dynamics over time, providing objective data for disease progression and treatment response. For ongoing patient management, AI-powered tools can monitor vital parameters, provide real-time feedback, and generate personalized health recommendations, especially beneficial in chronic conditions like COPD or for post-procedural cardiac monitoring.

Related Companies

Radin Health offers a comprehensive suite of AI-powered, cloud-based solutions designed to enhance operational efficiency across all stages of the radiology workflow. Their platform integrates a Radiology Information System (RIS), Picture Archiving and Communication System (PACS), AI-driven Dictation, and RADIN SELECT for workflow management. These solutions aim to improve efficiency and productivity for administrators, medical […]

Spectrum Dynamics Medical is a pioneering medical device company focused on transforming nuclear medicine from analog to digital technology. They specialize in developing high-definition, solid-state based nuclear imaging technology, including digital SPECT (Single Photon Emission Computed Tomography) and SPECT/CT systems. Their products aim to meet the clinical needs and workflow demands of diagnostic imaging departments […]

Siemens Medical Solutions USA, Inc., operating as Siemens Healthineers USA, is a prominent medical technology company with a rich history spanning over 175 years, dedicated to pioneering breakthroughs in healthcare. As a subsidiary of the global Siemens Healthineers AG, the company offers a comprehensive portfolio that is central to clinical decision-making across the entire healthcare […]

Siemens Healthineers is a leading global medical technology company that pioneers breakthroughs in healthcare. The company focuses on medical technology and diagnostics, offering a wide range of products including imaging systems, laboratory diagnostics, and advanced therapies. Their innovations aim to improve patient outcomes and make healthcare more accessible and sustainable. Siemens Healthineers has a strong […]

Samsung Medison Co. is a global medical equipment company specializing in diagnostic imaging devices, particularly ultrasound systems. Established in 1985, the company has become the largest manufacturer of ultrasound systems in Korea. Samsung Medison integrates advanced technologies, including information technology, video signal processing, semiconductors, and communication, into its medical equipment. This integration enables the development […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.